名稱 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocati |
型號 | CBP20188D |
報價 | ![]() |
特點 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocation |
產(chǎn)品搜索
相關(guān)文章
- Cell Rep:發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)!
- 可視化觀察黑色素瘤早期轉(zhuǎn)移,鑒定出一種新的治療靶標(biāo)
- NGS檢測血液腫瘤基因
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- 腸道守護(hù)者--GLP2R
- 【靶點模型+診斷質(zhì)控】BTK C481S的藥物開發(fā)和診斷
- TLR激動劑藥物細(xì)胞篩選模型
- 選擇性組蛋白去乙酰化酶抑制劑在腫瘤免疫治療中的作用及前景
- 增強(qiáng)腫瘤免疫療法新靶點:ADORA2B(腺苷A2B受體)
- BRAF系列標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Translocation > CBP20188DAI-Edigene® FGFR2(E17)- BICC1(E3) Translocati

- 詳細(xì)內(nèi)容
CBP20188D | |
Format | DNA |
Description | FGFR2, fibroblast growth factor receptor 2, is a receptor tyrosine kinase activated upon binding of the FGF ligand, which activates RAS-MAPK and PI3K-AKT pathways. Altered function of FGFR2 through activating mutations, fusions, and amplification increases cell proliferation and tumorigenesis and is observed in prostate, breast, lung, uterine, and ovarian cancers, while FGFR2 amplification and overexpression is commonly observed in gastric cancer. |
Technical Data | |
Left Gene | FGFR2 |
Left Breakpoint | chr10:1232****1:- (hg19) |
Right Gene | BICC1 |
Right Breakpoint | chr10:60****4:+ (hg19) |
%AF | N/A |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">